194 related articles for article (PubMed ID: 16185635)
1. [Anabolic therapy of osteoporosis].
Fernández-García D; Alonso G; Muñoz-Torres M
Med Clin (Barc); 2005 Sep; 125(9):341-5. PubMed ID: 16185635
[TBL] [Abstract][Full Text] [Related]
2. New anabolic agents in the treatment of osteoporosis.
Hough S
S Afr Med J; 2003 Oct; 93(10):754-6. PubMed ID: 14652963
[No Abstract] [Full Text] [Related]
3. [Anabolic therapy of osteoporosis].
Okopień B; Krysiak R; Labuzek K; Herman ZS
Pol Merkur Lekarski; 2005 Jul; 19(109):118-21. PubMed ID: 16194044
[TBL] [Abstract][Full Text] [Related]
4. New anabolic therapies in osteoporosis.
Rubin MR; Bilezikian JP
Endocrinol Metab Clin North Am; 2003 Mar; 32(1):285-307. PubMed ID: 12699304
[TBL] [Abstract][Full Text] [Related]
5. Anabolic agents and bone quality.
Sibai T; Morgan EF; Einhorn TA
Clin Orthop Relat Res; 2011 Aug; 469(8):2215-24. PubMed ID: 21132409
[TBL] [Abstract][Full Text] [Related]
6. Therapy for osteoporosis. Miscellaneous and experimental agents.
Reginster JY; Taquet AN; Gosset C
Endocrinol Metab Clin North Am; 1998 Jun; 27(2):453-63. PubMed ID: 9669149
[TBL] [Abstract][Full Text] [Related]
7. New anabolic therapies in osteoporosis.
Rubin MR; Bilezikian JP
Curr Opin Rheumatol; 2002 Jul; 14(4):433-40. PubMed ID: 12118181
[TBL] [Abstract][Full Text] [Related]
8. Formation-stimulating regimens other than sodium fluoride.
Riggs BL
Am J Med; 1993 Nov; 95(5A):62S-68S. PubMed ID: 8256799
[TBL] [Abstract][Full Text] [Related]
9. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
Marie PJ; Kassem M
Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
[TBL] [Abstract][Full Text] [Related]
10. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
11. [Anabolic therapy in osteoporosis--part 1].
Okopień B; Krysiak R; Labuzek K; Herman ZS
Pol Merkur Lekarski; 2005 Jun; 18(108):712-4. PubMed ID: 16124390
[TBL] [Abstract][Full Text] [Related]
12. Past and future of anabolic agents.
Ringe JD
Ann Med Interne (Paris); 2000 Oct; 151(6):482-9. PubMed ID: 11104928
[No Abstract] [Full Text] [Related]
13. Clinical review 123: Anabolic therapy for osteoporosis.
Rosen CJ; Bilezikian JP
J Clin Endocrinol Metab; 2001 Mar; 86(3):957-64. PubMed ID: 11238469
[TBL] [Abstract][Full Text] [Related]
14. Anabolics in osteoporosis: the emerging therapeutic tool.
Trivedi R; Mithal A; Chattopadhyay N
Curr Mol Med; 2010 Feb; 10(1):14-28. PubMed ID: 20205677
[TBL] [Abstract][Full Text] [Related]
15. Emerging anabolic treatments in osteoporosis.
Mosekilde L; Tørring O; Rejnmark L
Curr Drug Saf; 2011 Apr; 6(2):62-74. PubMed ID: 21524248
[TBL] [Abstract][Full Text] [Related]
16. Miscellaneous and experimental agents.
Reginster JY
Am J Med Sci; 1997 Jan; 313(1):33-40. PubMed ID: 9001164
[TBL] [Abstract][Full Text] [Related]
17. Treatment of osteoporosis: role of bone-forming agents.
Reginster JY; Halkin V; Henrotin Y; Gosset C
Osteoporos Int; 1999; 9 Suppl 2():S91-6. PubMed ID: 10525731
[No Abstract] [Full Text] [Related]
18. [Male osteoporosis: current treatments and future options].
Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S
Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284
[TBL] [Abstract][Full Text] [Related]
19. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
Garcés C; García LE
Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
[TBL] [Abstract][Full Text] [Related]
20. Investigational anabolic therapies for osteoporosis.
Trivedi R; Goswami R; Chattopadhyay N
Expert Opin Investig Drugs; 2010 Aug; 19(8):995-1005. PubMed ID: 20629616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]